New Covid pill from Merck

More from this show

The battle against Covid-19 has been focused on vaccines, but now there is a new development that may be able to help alongside mass vaccinations. We spoke with Doctor Jun Wang from the University of Arizona about a new pill that Merck has created.

To begin the conversation host Ted Simons asked the doctor to simply explain the pill.

Wang responded, “This is an anti-viral drug candidate that has a long history. It was not actually originally developed to target or inhibit the Coronavirus, it was actually originally developed to inhibit or target a few other viruses. Later on, this molecule has also been found to inhibit a number of other viruses; for example, ebola and, most importantly, the flu virus. Actually, right before the Covid-19 pandemic, this molecule was in a clinical trial for influenza variant infection, but with the Covid-19 outbreak the company which originally developed this molecule called the ridgeback, they wanted to see if this molecule works against the Sars-Cov-2 virus or not, which is the virus that caused the Covid-19 pandemic. And the interesting thing is from the experiment and the animal studies using mice, this molecule shows good efficacy in inhibiting Sars-Cov-2.”

Dr. Jun Wang, Associate Professor University of Arizona College of Pharmacy

National Memorial Day Concert image
aired May 28

National Memorial Day Concert

Endeavour Watch Party

“Endeavour” Season 9 Watch Party!

Super Why characters

Join a Super Why Reading Camp to play, learn and grow

NOVA will talk about how your brain determines your reality in
aired May 17

NOVA’s two part series on “Your Brain”

Subscribe to Arizona PBS Newsletters

STAY in touch

Subscribe to Arizona PBS Newsletters: